Which of the following best describes the mechanism of action of gabapentinoids (gabapentin, pregabalin) in neuropathic pain?
- A Blockade of sodium channels in peripheral nociceptors
- B Competitive antagonism at NMDA glutamate receptors in the dorsal horn
- C Inhibition of COX-2 enzyme in central sensitisation pathways
- D Binding to the α2δ subunit of voltage-gated calcium channels, reducing excitatory neurotransmitter release in spinal dorsal horn ✓
Explanation
Gabapentin and pregabalin bind to the α2δ-1 subunit of voltage-gated calcium channels in primary afferent terminals and spinal dorsal horn neurons. This reduces calcium influx, thereby decreasing the release of excitatory neurotransmitters (glutamate, substance P, CGRP) at synapses — attenuating central sensitisation and allodynia. They are first-line agents for neuropathic pain (diabetic neuropathy, post-herpetic neuralgia, fibromyalgia) and perioperative opioid-sparing. They are NOT sodium channel blockers (that is the mechanism of local anaesthetics and anticonvulsants like carbamazepine). Ketamine is the NMDA antagonist.
Reference: Morgan & Mikhail's Clinical Anesthesiology, 6th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.